Disorders of Sex Development (DSD) and Hypogonadism are genetically heterogeneous and include a broad spectrum of phenotypes. Recent advances in biology and medicine have introduced new technologies to study the genetics of DSD and hypogonadism and the mechanisms underlying their pathologies. Knowledge and understanding of these conditions have led to the development of successful therapies and novel tools to characterize them and provide better care to patients.

We invite investigators to contribute with original research articles as well as review articles to stimulate the understanding of molecular pathology underlying DSD and Hypogonadism, the development of strategies to treat these conditions, and the evaluation of outcomes. We are particularly interested in articles on the clinical characterization of DSD and hypogonadism, advances in molecular genetics and molecular diagnosis, and current concepts on treatment and long-term follow-up. Potential topics include, but are not limited to:

• Recent developments in inherited DSD or hypogonadism
• Advances in genetics of DSD or hypogonadism
• Latest technologies for clinical evaluation of DSD or hypogonadism
• Role of endocrine disruptors in DSD or hypogonadism
• Role of intrauterine growth in DSD
• Recent advances in treatment of DSD and hypogonadism
• Long-term follow-up of DSD or hypogonadism

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/ije/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable: